Communicable Disease Guidelines

The Chief Public Health Office provides direction and guidance on the management and control of communicable diseases in Prince Edward Island.  The following policies and guidelines contain information for health care providers regarding the prevention, identification and management of communicable diseases pursuant to Prince Edward Island’s Public Health Act and Notifiable Diseases and Conditions and Communicable Diseases Regulations.

These guidelines are routinely reviewed and updated as new evidence presents.

• Amoebiasis
• Campylobacteriosis
• Chlamydia  Chlamydia Fact Sheet
• Clostridium difficile Infection 
• COVID-19 (Novel Coronavirus)  Infection Prevention and Control of COVID-19 in LTC and CCF 
• Cryptosporidiosis 
• Ebola / Sudan Viral Disease Public Health Response Guidelines
• Giardiasis
• Hepatitis B (HBV) Guideline
• Invasive Haemophilus influenza serotype b (Hib)
• IGAS (Invasive Group A Streptococcus)
• IMD (Invasive Meningococcal Disease) 
• Influenza Control in Long Term Care
• Infection Control for Health Care Offices and Clinics
• Invasive Pneumococcal Disease (IPD)
• Lyme Disease (Management and Control) 
• Measles
• Methicillin Resistant Staphylococcus Aureus (MRSA)
• Monkeypox (MPX) National Monkeypox Information for Health Professionals Imvamune Vaccine Information Sheet
• Needlestick Guidelines (Blood and Body Fluids Exposure Guideline)
• Pertussis
• Physician Outpatient Office Guidelines for Respiratory Illness  PPE Guidance for Physician Offices
• Rabies 
• Salmonella
• Severe Acute Respiratory Infections (SARI)
• Shigellosis
• Tuberculosis (FAQs, TST Fact Sheet, Canadian TB Standards)
• Vancomycin-Resistant Enterococci (VRE) 
• Verotoxic E Coli (VTEC)
• Yersiniosis